Scholarly Activity

Department of Urology Peer-Reviewed Publications in 2024

James A. Brown, MD

Rolig B, Brown JA. Practical, cost-effective removal of Hem-o-lok Weck clip: a novel technique. Can J Urol. 2024 Oct;31(5):12019-12021.

Livorsi DJ, Packiam VT, Shi Q, Alberding SY, Carter KD, Brown JA, Mason JB, Weiss JP, Steinberg RL. A pilot intervention trial to reduce the use of post-procedural antimicrobials after common endourologic surgeries. Infect Control Hosp Epidemiol. 2024 Nov 7:1-7.

Christopher S. Cooper, MD

Baskin LS, Cao M, Li Y, Baker L, Cooper CS, Cunha GR. Ovotesticular cords and ovotesticular follicles: New histologic markers for human ovotesticular syndrome. J Pediatr Urol. 2024 Oct;20(5):799-809.

Dudley-Javoroski S, Cooper CS, Jackson JB, Zorn A, Carter KD, Shields RK. Tolerance for Ambiguity: Correlations With Medical and Physical Therapy Student Traits and Experiences Within the Learning Environment. Acad Med. 2024 Jun 1;99(6):644-653.

Cooper CS, Orzel JA, Bonnett MA, Zimmerman MB, Malicoat JR, Hlas AC, Storm DW, Lockwood GM. The Impact of the Distal Ureteral Diameter Ratio, Bladder Volume at Onset of Vesicoureteral Reflux, and/or Grade in Predictive Models of Clinical Outcomes in Children with Vesicoureteral Reflux. J Pediatr Urol. 2024 Aug;20(4):750.e1-750.e7.

Soukup DA, Pham HTD, Lence T, Edwards AB, Lockwood GM, Storm DW, Cooper CS. Correlation between renal sonographic measurements and differential renal function obtained from nuclear renography in children with unilateral hydronephrosis. J Pediatr Urol. 2024 Dec;20(6):1160-1165.

Erdman L, Rickard M, Drysdale E, Skreta M, Hua SB, Sheth K, Alvarez D, Velaer KN, Chua ME, Dos Santos J, Keefe D, Rosenblum ND, Bonnett MA, Weaver J, Xiang A, Fan Y, Viteri B, Cooper CS, Tasian GE, Lorenzo AJ, Goldenberg A. The Hydronephrosis Severity Index guides paediatric antenatal hydronephrosis management based on artificial intelligence applied to ultrasound images alone. Sci Rep. 2024 Oct 1;14(1):22748.

Willging AM, Lence T, Pham HTD, Cooper CS. The utility of renal sonographic measurements in differentiating children with grades 2, 3, and 4 hydronephrosis. J Pediatr Urol. 2024 Dec 28:S1477-5131(24)00682-X.

Bradley A. Erickson, MD

Paul CJ, Erickson BA, Nepple KG, Tracy CR. Does Rounding Order Bias Discharge Efficiency? Predictors of Discharge Timing on an Academic Urology Service. J Healthc Qual. 2024 Jan-Feb 01;46(1):12-21.

Erickson BA, Griffith JW, Wensheng G, Mengying Y, Herman T, Bradley CS, Clemens J, Farrar JT, Gupta P, Kreder KJ, Lai H, Naliboff BD, Newman DK, Rodriguez LV, Spitznagle T, Sutcliffe S, Sutherland SE, Taple BJ, Landis JR. Ecological momentary assessment of pelvic pain and urinary urgency variability in urologic chronic pelvic pain syndrome and their association with illness impact and quality of life: Findings from the multidisciplinary approach to the study of chronic pelvic pain symptom patterns study. Neurourol Urodyn. 2024 Apr;43(4):893-901.

Matta R, Keihani S, Hebert K, Horns JJ, Nirula R, McCrum M, McCormick BJ, Gross JA, Joyce RP, Rogers DM, Wang SS, Hagedorn JC, Selph JP, Sensenig RL, Moses RA, Dodgion CM, Gupta S, Mukherjee K, Majercik S, Broghammer JA, Schwartz I, Elliott SP, Breyer BN, Baradaran N, Zakaluzny S, Erickson BA, Miller BD, Askari R, Carrick MM, Burks FN, Norwood S, Myers JB; in conjunction with the Trauma and Urologic Reconstruction Network of Surgeons. Proposed revision of the American Association for Surgery of Trauma renal trauma organ injury scale: Secondary analysis of the Multi-Institutional Genitourinary Trauma Study. J Trauma Acute Care Surg. 2024 Aug 1;97(2):205-212.

Faidley KN, Botkin HE, Loeffler BT, Mott SL, Hansen SC, Hill EK, Erickson BA. Longitudinal Outcomes of Malignant Ureteral Obstruction Secondary to Ovarian Cancer: Predictors of Resolution and the Role of Surgical Management. Urology. 2024 Apr;186:101-106.

Gutierrez WR, Luo Y, Dahmoush L, Oleson JJ, Schlaepfer CH, Breyer BN, Elliott SP, Myers JB, Vanni AJ, Juhr D, Christel KN, Erickson BA. Deep Phenotyping the Anterior Urethral Stricture: Characterizing the Relationship Between Inflammation, Fibrosis, Patient History and Disease Pathophysiology. J Urol. 2024 Jul;212(1):153-164.

Lai HH, Rutlin J, Smith AR, Helmuth ME, Hokanson JA, Yang CC, Clemens JQ, Magnotta VA, Bretschneider CE, Kenton K, DeLancey JOL, John K, Kirkali Z, Shimony JS; LURN Study Group. Structural Changes in Brain White Matter Tracts Associated With Overactive Bladder Revealed by Diffusion Tensor Magnetic Resonance Imaging: Findings From a Symptoms of Lower Urinary Tract Dysfunction Research Network Cross-Sectional Case-Control Study. J Urol. 2024 Aug;212(2):351-361.

Patel HV, Li KD, Rourke K, Smith TG 3rd, Voelzke BB, Myers JB, Broghammer JA, Alsikafi NF, Buckley JC, Zhao LC, Elliott SP, Vanni AJ, Peterson AC, Erickson BA, Breyer BN. The Impact of Social Deprivation on Anterior Urethral Stricture Recurrence After Urethroplasty - A Trauma and Urologic Reconstructive Network of Surgeons (TURNS) Analysis. J Urol. 2024 Dec;212(6):882-890.

Schlaepfer CH, Hansen SC, Shane DM, Erickson BA. Determining the Severity of Benign Urologic Health States in Men Using Utilities Measures. Urology. 2025 Jan;195:184-190.

Erickson BA, Tuong MN, Zorn AN, Schlaepfer CH, Alsikafi NF, Breyer BN, Broghammer JA, Buckley JC, Elliott SP, Myers JB, Peterson AC, Rourke KF, Smith TG 3rd, Vanni AJ, Voelzke BB, Zhao LC. Development and validation of the length, segment, and etiology (LSE) anterior urethral stricture disease staging system using longitudinal urethroplasty outcomes data from the Trauma and Urologic Reconstruction Network of Surgeons. J Urol. 2024 Dec 9:101097JU0000000000004369.

Helen Y. Hougen, MD

McElree IM, Mott SL, Hougen HY, Packiam VT, O’Donnell MA, Steinberg RL. Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situ. Urol Oncol. 2024 Jul;42(7):221.e9-221.e16. 

Ajami T, Han S, Blachman-Braun R, Hougen HY, Avda Y, Gonzalgo ML, Nahar B, Punnen S, Parekh DJ, Reis IM, Ritch CR. Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re-staging TURBT and Intravesical Adjuvant Therapy. BJUI Compass. 2024 Apr 17;5(8):799-805.

McElree IM, Packiam VT, Steinberg RL, Hougen HY, Mott SL, Abou Chakra M, Zakharia Y, O’Donnell MA. Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder Tumor. Cancers (Basel). 2024 Jul 17;16(14):2561.

Goglia AG, Alshalalfa M, Khan A, Isakov DR, Hougen HY, Swami N, Kannikal J, Mcbride SM, Gomez DR, Punnen S, Nguyen PL, Iyengar P, Antonarakis ES, Mahal BA, Dee EC. Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers. J Natl Cancer Inst. 2025 Jan 1;117(1):188-197.

Hougen HY, Reis IM, Han S, Prakash NS, Thomas J, Stoyanova R, Castillo RP, Kryvenko ON, Ritch CR, Nahar B, Gonzalgo ML, Gaston SM, Abramowitz MC, Dal Pra A, Mahal BA, Pollack A, Parekh DJ, Punnen S. Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score. Prostate Cancer Prostatic Dis. 2025 Mar;28(1):180-186.

Thomas J, Jain A, Hirpara R, Blachman-Braun R, Hougen HY, Soodana-Prakash N, Velasquez MC, Ajami T, Nahar B, Gonzalgo ML, Kava B, Punnen S, Parekh DJ, Ritch CR. Impact of BMI Category on Recurrence and Progression of Nonmuscle Invasive Bladder Cancer Prognosis. Clin Genitourin Cancer. 2025 Feb;23(1):102286.

McElree IM, Packiam VT, Steinberg RL, Hougen HY, Abou Chakra M, Mott SL, O’Donnell MA. Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial Carcinoma. Cancers (Basel). 2024 Dec 10;16(24):4126.

Karl J. Kreder, MD

Erickson BA, Griffith JW, Wensheng G, Mengying Y, Herman T, Bradley CS, Clemens J, Farrar JT, Gupta P, Kreder KJ, Lai H, Naliboff BD, Newman DK, Rodriguez LV, Spitznagle T, Sutcliffe S, Sutherland SE, Taple BJ, Landis JR. Ecological momentary assessment of pelvic pain and urinary urgency variability in urologic chronic pelvic pain syndrome and their association with illness impact and quality of life: Findings from the multidisciplinary approach to the study of chronic pelvic pain symptom patterns study. Neurourol Urodyn. 2024 Apr;43(4):893-901.

Clemens JQ, Locke K Jr, Landis JR, Kreder K, Rodriguez LV, Yang CC, Tu FF, Harte SE, Schrepf A, Farrar JT, Sutcliffe S, Naliboff BD, Williams DA, Afari N, Spitznagle T, Taple BJ, Lai HH; Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. Validation of a simple body map to measure widespread pain in urologic chronic pelvic pain syndrome: A MAPP research network study. Neurourol Urodyn. 2024 Mar;43(3):727-737. doi: 10.1002/nau.25400. Epub 2024 Jan 25. PMID: 38270336.

Lai HH, Rutlin J, Smith AR, Helmuth ME, Hokanson JA, Yang CC, Clemens JQ, Magnotta VA, Bretschneider CE, Kenton K, DeLancey JOL, John K, Kirkali Z, Shimony JS; LURN Study Group. Structural Changes in Brain White Matter Tracts Associated With Overactive Bladder Revealed by Diffusion Tensor Magnetic Resonance Imaging: Findings From a Symptoms of Lower Urinary Tract Dysfunction Research Network Cross-Sectional Case-Control Study. J Urol. 2024 Aug;212(2):351-361.

Ashton L, Nakatsuka H, Johnson CM, Kenne K, Kreder KJ, Kruse R, Wendt L, Takacs EB, Vollstedt AJ. A Single Injection of Platelet-Rich Plasma Injection for the Treatment of Stress Urinary Incontinence in Females: A Randomized Placebo-Controlled Trial. Urology. 2024 Nov;193:63-68. doi: 10.1016/j.urology.2024.06.047. Epub 2024 Jun 26. PMID: 38942391.

Cameron AP, Yang CC, Bradley CS, Griffith JW, Kirkali Z, Clemens JQ, Kreder KJ, Kenton KS, Andreev VP, Amundsen CL, Jelovsek JE, Helfand BT, Lai HH; LURN Study Group. Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN): An introduction to the Urinary Urgency Phenotyping Protocol LURN II. Neurourol Urodyn. 2024 Nov;43(8):1800-1808.

Leech KA, Kettlety SA, Mack WJ, Kreder KJ, Schrepf A, Kutch JJ. Brain predicted age in chronic pelvic pain: a study by the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network. Pain. 2024 Oct 16.

Owens RG, Tracy CR, Humble RM, Kreder KJ. Unusual Presentation of Ureteral Hunner Lesion: A Case Report. JU Open Plus. 2024;2(11):e00113.

Farrar J, Locke K, Clemens J, Griffith J, Harte S, Kirkali Z, Kreder K, Krieger J, Lai HH, Moldwin R, Mullins C, Naliboff B, Pontari M, Rodríguez L, Schaeffer A, Stephens-Shields A, Sutcliffe S, Taple B, Williams D, Landis J. Widespread pain phenotypes impact treatment efficacy results in randomized clinical trials for interstitial cystitis/bladder pain syndrome: A MAPP Network study. Pain. 2024 Nov 5.

Gina M. Lockwood, MD

Wehbi EJ, Davis-Dao CA, Williamson SH, Herndon CDA, Chamberlin JD, Dudley AG, Cannon S, Lockwood GM, Kern NG, Zee RS, Braga LH, Welch V, Chuang KW, McGrath M, Stephany HA, Khoury AE. The conundrum of high-grade hydronephrosis with non-obstructive drainage on diuretic renography. J Pediatr Urol. 2024;20 Suppl 1:S11-S17.

Cooper CS, Orzel JA, Bonnett MA, Zimmerman MB, Malicoat JR, Hlas AC, Storm DW, Lockwood GM. The Impact of the Distal Ureteral Diameter Ratio, Bladder Volume at Onset of Vesicoureteral Reflux, and/or Grade in Predictive Models of Clinical Outcomes in Children with Vesicoureteral Reflux. J Pediatr Urol. 2024 Aug;20(4):750.e1-750.e7.

Soukup DA, Pham HTD, Lence T, Edwards AB, Lockwood GM, Storm DW, Cooper CS. Correlation between renal sonographic measurements and differential renal function obtained from nuclear renography in children with unilateral hydronephrosis. J Pediatr Urol. 2024 Dec;20(6):1160-1165.

Owens RG, Lockwood G, Storm D. Breaking the Rules: Upper Pole Ureteropelvic Junction Obstruction Causing Massive Urinary Tract Dilation in a Neonate with Prenatal Diagnosis of Multicystic Dysplastic Kidney. Urology. 2025 Feb;196:211-213.

Yi Luo, MD

Gutierrez WR, Luo Y, Dahmoush L, Oleson JJ, Schlaepfer CH, Breyer BN, Elliott SP, Myers JB, Vanni AJ, Juhr D, Christel KN, Erickson BA. Deep Phenotyping the Anterior Urethral Stricture: Characterizing the Relationship Between Inflammation, Fibrosis, Patient History and Disease Pathophysiology. J Urol. 2024 Jul;212(1):153-164.

Abou Chakra M, Luo Y, Duquesne I, O’Donnell MA. Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder Cancer. Front Biosci (Landmark Ed). 2024 Aug 21;29(8):295.

Saito T, Minagawa T, Yoshimura N, Luo Y, Akiyama Y. Experimental murine models of interstitial cystitis/bladder pain syndrome: A review. Histol Histopathol. 2024 Oct 23:18837.

Kenneth G. Nepple, MD

Paul CJ, Erickson BA, Nepple KG, Tracy CR. Does Rounding Order Bias Discharge Efficiency? Predictors of Discharge Timing on an Academic Urology Service. J Healthc Qual. 2024 Jan-Feb 01;46(1):12-21.

Chua KJ, Kronstedt S, Kaldany A, Srivastava A, Doppalapudi SK, Liu H, Tarhini AA, Gatti-Mays M, Gaughan E, Hu-Lieskovan S, Aljumaily R, Nepple K, Schneider B, Sterling J, Singer EA. Comparing the rate of immunotherapy treatment change due to toxicity by sex. Cancer Rep (Hoboken). 2024 Feb;7(2):e1932.

Khan Q, Myers B, Bowar B, Khan M, Mullaney H, Gainey J, Schneider R, Dahmoush L, Nepple KG, Byrne JD. Case report: Robotically visualized and biopsy-confirmed peritoneal carcinomatosis as initial identification of metastatic prostate adenocarcinoma in a patient with a history of prostatic urethral lift. Front Oncol. 2024 Jan 19;13:1284688.

Leyderman M, McElree IM, Nepple KG, Zakharia Y, Ghodoussipour S, Packiam VT. Management of Renal Cell Carcinoma With Supradiaphragmatic Inferior Vena Cava Thrombus Diagnosed During Acute COVID-19 Infection. Cureus. 2024 Mar 5;16(3):e55565.

Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, Cleland S, Ferreiro-Iglesias A, Scheet P, Liu A, Wu C, Antwi SO, Larkin J, Zequi SC, Sun M, Hikino K, Hajiran A, Lawson KA, Cárcano F, Blanchet O, Shuch B, Nepple KG, Margue G, Sundi D, Diver WR, Folgueira MAAK, van Bokhoven A, Neffa F, Brown KM, Hofmann JN, Rhee J, Yeager M, Cole NR, Hicks BD, Manning MR, Hutchinson AA, Rothman N, Huang WY, Linehan WM, Lori A, Ferragu M, Zidane-Marinnes M, Serrano SV, Magnabosco WJ; BioBank Japan Project; Vilas A, Decia R, Carusso F, Graham LS, Anderson K, Bilen MA, Arciero C, Pellegrin I, Ricard S; FinnGen; Scelo G, Banks RE, Vasudev NS, Soomro N, Stewart GD, Adeyoju A, Bromage S, Hrouda D, Gibbons N, Patel P, Sullivan M, Protheroe A, Nugent FI, Fournier MJ, Zhang X, Martin LJ, Komisarenko M, Eisen T, Cunningham SA, Connolly DC, Uzzo RG, Zaridze D, Mukeria A, Holcatova I, Hornakova A, Foretova L, Janout V, Mates D, Jinga V, Rascu S, Mijuskovic M, Savic S, Milosavljevic S, Gaborieau V, Abedi-Ardekani B, McKay J, Johansson M, Phouthavongsy L, Hayman L, Li J, Lungu I, Bezerra SM, Souza AG, Sares CTG, Reis RB, Gallucci FP, Cordeiro MD, Pomerantz M, Lee GM, Freedman ML, Jeong A, Greenberg SE, Sanchez A, Thompson RH, Sharma V, Thiel DD, Ball CT, Abreu D, Lam ET, Nahas WC, Master VA, Patel AV, Bernhard JC, Freedman ND, Bigot P, Reis RM, Colli LM, Finelli A, Manley BJ, Terao C, Choueiri TK, Carraro DM, Houlston R, Eckel-Passow JE, Abbosh PH, Ganna A, Brennan P, Gu J, Chanock SJ. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet. 2024 May;56(5):809-818.

Kohlmann W, Nix DA, Pauley K, Greenberg S, Atkinson A, Boucher KM, Kolesar J, Singer EA, Edge SB, Churchman ML, Graham L, Salhia B, Sanchez A, Zakharia Y, Nepple KG, Schneider BP, Byrne L, Jain RK, Chahoud J, Feng BJ, Gupta S. Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics. JCO Precis Oncol. 2024 Jun;8:e2300697.

Dutta D, Guo X, Winter TD, Jahagirdar O; Renal Cancer Genetics Consortium; Ha E, Susztak K, Machiela MJ, Chanock SJ, Purdue MP. Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma. Am J Hum Genet. 2024 Aug 12:S0002-9297(24)00256-8.

Davis HA, Hoberg AA, Jacobus LS, Nepple K, Seaman AT, Sorensen J, Weiner GJ, Gilbertson-White S. Leveraging oncology collaborative networks and biomedical informatics data resources to rapidly recruit and enroll rural residents into oncology quality of life clinical trials. J Clin Transl Sci. 2024 Sep 23;8(1):e135.

Finnerty MC, Leach FE 3rd, Zakharia Y, Nepple KG, Bartlett MG, Henry MD, Cummings BS. Identification of blood lipid markers of docetaxel treatment in prostate cancer patients. Sci Rep. 2024 Sep 27;14(1):22069.

Lakritz S, Nicklawsky A, Alami V, Kohli M, Moskaluk C, Riedlinger G, Salhia B, Singer EA, Naqash AR, Nepple K, Edge S, Myint Z, Kolesar J, Adra N, Flaig T, Graham LS. Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair Mutations. Clin Genitourin Cancer. 2025 Feb;23(1):102293.

Michael A. O’Donnell, MD

Abou Chakra M, Packiam VT, Duquesne I, Peyromaure M, McElree IM, O’Donnell MA. Combination intravesical chemotherapy for non-muscle invasive bladder cancer (NMIBC) as first-line or rescue therapy: where do we stand now. Expert Opin Pharmacother. 2024 Feb;25(2):203-214.

Abou Chakra M, Duquesne I, Peyromaure M, Mott SL, Moussa M, O’Donnell MA. Impact of bladder cancer family history on the prognosis of patients with non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG). Expert Opin Pharmacother. 2024 Feb;25(3):315-324.

Abou Chakra M, Moussa M, O’Donnell MA. Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder cancer: tips and tricks for better efficacy and tolerability. J Chemother. 2024 Mar 4:1-4.

Arham AB, Robinson RA, Chakra MA, O’Donnell MA. Leiomyosarcoma of the prostate: a novel approach to treatment-case report and review of the literature. J Surg Case Rep. 2024 Mar 15;2024(3):rjae138.

Moussa M, Abou Chakra M, Shore ND, Papatsoris A, Farahat Y, O’Donnell MA. Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists. Arch Ital Urol Androl. 2024 Mar 19:12244.

Hage L, O’Donnell MA, Abou Chakra M, Kime A, Sibony M, Peyromaure M, Duquesne I. Inflammatory myofibroblastic tumor of the urinary bladder: A systematic review of the literature and report of a case. Indian J Urol. 2024 Apr-Jun;40(2):88-95.

McElree IM, Mott SL, Hougen HY, Packiam VT, O’Donnell MA, Steinberg RL. Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situ. Urol Oncol. 2024 Jul;42(7):221.e9-221.e16. 

Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J Jr, Lane BR, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O’Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Efficacy of Intravesical Nadofaragene Firadenovec for Patients with BCG-Unresponsive Non-muscle Invasive Bladder Cancer: 5 Year Follow-Up from a Phase 3 Trial. J Urol. 2024 Jul;212(1):74-86.

Abou Chakra M, McElree IM, Packiam VT, Mott SL, O’Donnell MA. Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer. Urol Oncol. 2024 Sep;42(9):289.e13-289.e21.

Abou Chakra M, Shore ND, Brown ES, Du GJ, O’Donnell MA. Establishing an Intravesical Doublet Chemotherapy Clinic for Nonmuscle-Invasive Bladder Cancer Patients. Urol Pract. 2024 Jul;11(4):613-623.

Abou Chakra M, Duquesne I, Peyromaure M, Mott SL, Moussa M, O’Donnell MA. A Multinational, Multi-Institutional Study Assessing the Impact of Diabetes Mellitus on the Prognosis of Patients with Non-Muscle Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin. Nutr Cancer. 2024;76(9):861-869.

McElree IM, Packiam VT, Steinberg RL, Hougen HY, Mott SL, Abou Chakra M, Zakharia Y, O’Donnell MA. Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder Tumor. Cancers (Basel). 2024 Jul 17;16(14):2561.

Chakra MA, Lassila R, El Beayni N, Mott SL, O’Donnell MA. Prognostic role of the neutrophil/lymphocyte ratio in high-risk BCG-naïve non-muscle-invasive bladder cancer treated with intravesical gemcitabine/docetaxel. BJU Int. 2025 Jan;135(1):125-132.

Abou Chakra M, Luo Y, Duquesne I, O’Donnell MA. Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder Cancer. Front Biosci (Landmark Ed). 2024 Aug 21;29(8):295.

Li R, Hensley PJ, Gupta S, Al-Ahmadie H, Babjuk M, Black PC, Brausi M, Bree KK, Fernández MI, Guo CC, Horowitz A, Lamm DL, Lerner SP, Lotan Y, Mariappan P, McConkey D, Mertens LS, Mir C, Ross JS, O’Donnell M, Palou J, Pohar K, Steinberg G, Soloway M, Spiess PE, Svatek RS, Tan WS, Taoka R, Buckley R, Kamat AM. Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection. Eur Urol. 2024 Dec;86(6):516-527.

Taylor JI, Kamat AM, O’Donnell MA, Annapureddy D, Howard J, Tan WS, McElree I, Davaro F, Yim K, Harrington S, Dyer E, Black AJ, Kanabur P, Roumiguié M, Lerner S, Black PC, Raman JD, Preston MA, Steinberg G, Huang W, Li R, Packiam VT, Woldu SL, Lotan Y. Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer. BJU Int. 2025 Feb;135(2):260-268.

Contieri R, Soloway MS, Gontero P, Herr H, Kassouf W, Mertens LS, Moschini M, O’Donnell M, Palou J, Psutka SP, Rouprêt M, Teoh JYC, Kamat AM. Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG). Eur Urol Oncol. 2025 Feb;8(1):179-189.

Lotan Y, Krishna V, Abuzeid WM, Launer B, Chang SS, Krishna V, Shingi S, Gordetsky JB, Gerald T, Woldu S, Shkolyar E, Hayne D, Redfern A, Spalding L, Stewart C, Eyzaguirre E, Imtiaz S, Narayan VM, Packiam VT, O’Donnell MA, Li R, Baekelandt L, Joniau S, Zuiverloon T, Fernandez MI, Schultz M, Hensley PJ, Allison D, Taylor JA, Hamza A, Kamat A, Nimgaonkar V, Sonawane S, Miller DL, Watson D, Vrabac D, Joshi A, Shah JB, Williams SB. Predicting response to intravesical BCG in high-risk non-muscle invasive bladder cancer using an artificial intelligence-powered pathology assay: development and validation in an international 12 center cohort. J Urol. 2025 Feb;213(2):192-204.

Abou Chakra M, Packiam VT, McElree IM, Mott SL, O’Donnell MA. The efficacy of sequential intravesical gemcitabine and docetaxel versus BCG for the treatment of European association of urology very-high risk non-muscle invasive bladder cancer. Urol Oncol. 2024 Nov 25:S1078-1439(24)00692-6.

McElree IM, Packiam VT, Steinberg RL, Hougen HY, Abou Chakra M, Mott SL, O’Donnell MA. Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial Carcinoma. Cancers (Basel). 2024 Dec 10;16(24):4126.

Taylor J, Kamat AM, Annapureddy D, Khene ZE, Howard J, Tan WS, McElree IM, Facundo D, Yim K, Harrington S, Dyer E, Black AJ, Kanabur P, Roumiguié M, Lerner S, Black PC, Raman J, Preston M, Steinberg G, Huang W, Li R, Packiam VT, Woldu SL, Lotan Y, O’Donnell MA. Oncologic outcomes of sequential intravesical gemcitabine and docetaxel compared with bacillus Calmette-Guérin in patients with bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer. Eur Urol Oncol. 2024 Dec 17:S2588-9311(24)00288-8.

Ryan L. Steinberg, MD

McElree IM, Mott SL, Hougen HY, Packiam VT, O’Donnell MA, Steinberg RL. Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situ. Urol Oncol. 2024 Jul;42(7):221.e9-221.e16.

Kominsky HD, Dai J, Morgan TN, Garbens A, Steinberg RL, Cadeddu JA. Evaluating acetate as a renoprotective agent following kidney ischemia in a porcine model. J Endourol. 2024 Jul;38(7):701-706.

McElree IM, Packiam VT, Steinberg RL, Hougen HY, Mott SL, Abou Chakra M, Zakharia Y, O’Donnell MA. Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder Tumor. Cancers (Basel). 2024 Jul 17;16(14):2561.

Ganesan V, Steinberg RL, Trivedi H, Sorokin I, Johnson BA, Gahan JC. Scheduled intravenous ketorolac is safe and reduces narcotic use after robotic-assisted simple prostatectomy. J Robot Surg. 2024 Oct 3;18(1):358.

Kong Z, Johnson BA, Maalouf NM, Nakada SY, Tracy CR, Steinberg RL, Miller N, Antonelli JA, Lotan Y, Pearle MS, Liu YL. Predicting urinary stone recurrence: a joint model analysis of repeated 24-hour urine collections from the MSTONE database. Urolithiasis. 2024 Nov 1;52(1):156.

Livorsi DJ, Packiam VT, Shi Q, Alberding SY, Carter KD, Brown JA, Mason JB, Weiss JP, Steinberg RL. A pilot intervention trial to reduce the use of post-procedural antimicrobials after common endourologic surgeries. Infect Control Hosp Epidemiol. 2024 Nov 7:1-7.

McElree IM, Packiam VT, Steinberg RL, Hougen HY, Abou Chakra M, Mott SL, O’Donnell MA. Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial Carcinoma. Cancers (Basel). 2024 Dec 10;16(24):4126.

Chad R. Tracy, MD

Paul CJ, Erickson BA, Nepple KG, Tracy CR. Does Rounding Order Bias Discharge Efficiency? Predictors of Discharge Timing on an Academic Urology Service. J Healthc Qual. 2024 Jan-Feb 01;46(1):12-21.

Bevill MD, Drobish JN, Flynn KJ, Rajput, M, Metz C, Tracy CR, Gellhaus PT. Does a large prostate size, small lesion volume, or long needle distance from the probe to the lesion reduce magnetic resonance imaging–targeted cancer detection?. Curr Urol. 2024 Jun;18(2):144-147.

Alzubaidi AN, Zheng A, Said M, Fan X, Maidaa M, Owens RG, Yudovich M, Pursnani S, Owens RS, Stringer T, Tracy CR, Raman JD. Prior Negative Biopsy, PSA Density, and Anatomic Location Impact Cancer Detection Rate of MRI-Targeted PI-RADS Index Lesions. Curr Oncol. 2024 Aug 1;31(8):4406-4413.

Stubbee RA, Orzel J, Tracy CR. Best Practices in Treatment of Fungal Urinary Tract Infections. Urol Clin North Am. 2024 Nov;51(4):483-492.

Kong Z, Johnson BA, Maalouf NM, Nakada SY, Tracy CR, Steinberg RL, Miller N, Antonelli JA, Lotan Y, Pearle MS, Liu YL. Predicting urinary stone recurrence: a joint model analysis of repeated 24-hour urine collections from the MSTONE database. Urolithiasis. 2024 Nov 1;52(1):156.

Owens RG, Tracy CR, Humble RM, Kreder KJ. Unusual Presentation of Ureteral Hunner Lesion: A Case Report. JU Open Plus. 2024;2(11):e00113.

Annah J. Vollstedt, MD

Burns RT, Orzel J, Wadensweiler P, Kenne K, Nakastuka H, Kovacevic N, Aswani Y, Ann Gormley E, Padamanabhan P, Powell CR, Vollstedt A, Takacs E. Radiation exposure during sacral neuromodulation lead placement: Multi-institutional descriptive study. Neurourol Urodyn. 2024 Mar;43(3):595-603.

Johnson CM, Bradley CS, Kenne KA, Rabice S, Takacs E, Vollstedt A, Kowalski JT. Evaluation of ChatGPT for Pelvic Floor Surgery Counseling. Urogynecology (Phila). 2024 Mar 1;30(3):245-250.

Johnson C, Vollstedt A, Nakatsuka H, Orzel J, Takacs EB. Cosmetic and functional impact of fascia lata harvest for use in surgery for stress urinary incontinence. Neurourol Urodyn. 2024 Jun;43(5):1185-1191.

Tabakin AL, De Rosa P, Ellis E, Grajales V, Orzel J, Overholt TL, Goh M, Kraft KH, Smith-Mathus G, Simma-Chiang V, Stearns G, Vollstedt A, Taylor JM. Increasing Diversity, Equity, and Inclusion in Urology Residency Recruitment: Recommendations from the Society of Women in Urology. Urology. 2024 Sep:191:193-199.

Ashton L, Nakatsuka H, Johnson CM, Kenne K, Kreder KJ, Kruse R, Wendt L, Takacs EB, Vollstedt AJ. A Single Injection of Platelet-Rich Plasma Injection for the Treatment of Stress Urinary Incontinence in Females: A Randomized Placebo-Controlled Trial. Urology. 2024 Nov;193:63-68.

Buford K, Eisner H, Vollstedt A, Friedman B, Gilleran J, Zwaans BMM, Peters KM, Padmanabhan P. Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study. Int Neurourol J. 2024 Dec;28(4): 278-284.

Moshe Wald, MD

Wald M. Scrotal Trauma Treatment and Outcomes. WMJ. 2024 Sep;123(4):166-171.